Albuterol Breathing Treatment Age Guidelines

Delivery Method Considerations by Age

The American Academy of Allergy, Asthma, and Immunology recommends that children <5 years old use a metered-dose inhaler (MDI) with a spacer/valved holding chamber and face mask, as they may not be able to cooperate with other delivery methods 1, 2
Children under 4 years old may not generate sufficient inspiratory flow to activate an autohaler, and parents must assist with MDI plus valved holding chamber or nebulizer administration 2, 3
Face mask use combined with low tidal volumes results in lower aerosol delivery in younger infants 3

The National Asthma Education and Prevention Program (NAEPP) designates albuterol as the drug of choice for acute bronchospasm across all age groups, and as a short-acting beta-agonist (SABA) that relaxes smooth muscle and provides relief of acute symptoms 1, 5
Regular use of albuterol exceeding 2 days/week for symptom control indicates poor asthma control, according to the NAEPP Expert Panel Report 3 1, 2

The American Academy of Pediatrics recommends a nebulizer dose of 0.63 mg/3 mL for routine use in children <5 years old, and 1.25-2.5 mg in 3 mL saline for acute exacerbations 2
For children 5-11 years old, the recommended nebulizer dose is 1.25-5 mg in 3 mL saline 2
The NAEPP recommends an MDI dose of 1-2 puffs (200 mcg/puff) every 4-6 hours as needed, and may double the usual dose for mild exacerbations 1, 2

Common adverse effects of albuterol include tachycardia, skeletal muscle tremor, hypokalemia, headache, and hyperglycemia, according to the American Academy of Allergy, Asthma, and Immunology 1, 2
Increasing albuterol use or lack of expected effect indicates diminished asthma control and requires reassessment of controller therapy, as stated by the NAEPP Expert Panel Report 3 1, 2

Preterm infants with post-prematurity respiratory disease (PPRD) may benefit from a trial of bronchodilator therapy for recurrent respiratory symptoms, with response rates varying from 35% to 55%, according to the American Thoracic Society 6